Metlife (MET) Stock Forecast & Price Target

Compare

2,872 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MET Analyst Ratings

Strong Buy

11 Buy

2 Hold

0 Sell

Based on 13 analysts giving stock ratings to

Metlife

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MET Stock 12 Month Forecast

Average Price Target

$94.75

▲(17.22% Upside)

Based on 13 Wall Street analysts offering 12 month price targets for Metlife in the last 3 months. The average price target is $94.75 with a high forecast of $108.00 and a low forecast of $82.00. The average price target represents a 17.22% change from the last price of $80.83.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"72":"$72","109":"$109","81.25":"$81.3","90.5":"$90.5","99.75":"$99.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":108,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$108.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":94.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$94.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":82,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$82.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[72,81.25,90.5,99.75,109],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.45,76.1076923076923,78.76538461538462,81.42307692307692,84.08076923076923,86.73846153846154,89.39615384615385,92.05384615384615,94.71153846153847,97.36923076923077,100.02692307692308,102.68461538461538,105.34230769230768,{"y":108,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.45,75.08846153846154,76.72692307692309,78.36538461538461,80.00384615384615,81.6423076923077,83.28076923076924,84.91923076923077,86.5576923076923,88.19615384615385,89.83461538461539,91.47307692307692,93.11153846153846,{"y":94.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.45,74.1076923076923,74.76538461538462,75.42307692307692,76.08076923076923,76.73846153846154,77.39615384615385,78.05384615384615,78.71153846153847,79.36923076923077,80.02692307692308,80.68461538461538,81.34230769230768,{"y":82,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":73.07,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.32,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.5,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.24,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.04,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.15,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.68,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.9,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.95,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.64,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.08,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.48,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.45,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$108.00

Average Price Target$94.75

Lowest Price Target$82.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Andrew Kligerman

TD Cowen

$90→$91

Buy

12.58%

Upside

Reiterated

08/22/25

TD Cowen Sticks to Their Buy Rating for Metlife (MET)We reiterate Buy.

Bob Huang

Morgan Stanley

$98→$94

Buy

16.29%

Upside

Reiterated

08/18/25

Morgan Stanley Keeps Their Buy Rating on Metlife (MET)MET.N MetLife Inc. Overweight with price target change from 98.00 to 94.00.

Jimmy Bhullar

J.P. Morgan

$95→$94

Buy

16.29%

Upside

Reiterated

08/14/25

J.P. Morgan Sticks to Its Buy Rating for Metlife (MET)JPMorgan analyst Jimmy Bhullar lowered the price target on MetLife (NYSE: MET) to $94.00 (from $95.00) while maintaining a Overweight rating.

Jack Matten

BMO Capital

$90→$82

Hold

1.45%

Upside

Reiterated

08/13/25

BMO Capital Sticks to Its Hold Rating for Metlife (MET)BMO Capital analyst Jack Matten lowered the price target on MetLife (NYSE: MET) to $82.00 (from $90.00) while maintaining a Market Perform rating.

Ryan Krueger

KBW

$94→$92

Buy

13.82%

Upside

Reiterated

08/12/25

KBW Keeps Their Buy Rating on Metlife (MET)

Suneet Kamath

Jefferies

$100→$103

Buy

27.43%

Upside

Reiterated

08/11/25

Jefferies Reaffirms Their Buy Rating on Metlife (MET)Jefferies analyst Suneet Kamath raised the price target on MetLife (NYSE: MET) to $103.00 (from $100.00) while maintaining a Buy rating.

Elyse Greenspan

Wells Fargo

$97→$95

Buy

17.53%

Upside

Reiterated

08/11/25

MetLife price target lowered to $95 from $97 at Wells FargoMetLife price target lowered to $95 from $97 at Wells Fargo

Thomas Gallagher

Evercore ISI

$110→$108

Buy

33.61%

Upside

Reiterated

08/08/25

Evercore ISI Sticks to Their Buy Rating for Metlife (MET)

John Barnidge

Piper Sandler

$94

Buy

16.29%

Upside

Reiterated

08/07/25

Analysts' Opinions Are Mixed on These Financial Stocks: CF Bankshares (NASDAQ: CFBK), Metlife (NYSE: MET) and TriplePoint Venture Growth (NYSE: TPVG)

Michael Ward CFA

UBS

$94→$91

Buy

12.58%

Upside

Reiterated

08/07/25

Metlife (MET) Receives a Buy from UBS

Alex Scott

Barclays

$94→$93

Buy

15.06%

Upside

Reiterated

08/07/25

Barclays Sticks to Its Buy Rating for Metlife (MET)

Joshua Shanker

Bank of America Securities

$100

Buy

23.72%

Upside

Reiterated

08/06/25

Analysts Conflicted on These Financial Names: Carlyle Group (NASDAQ: CG), Quilter (Other OTC: QUILF) and Metlife (NYSE: MET)

Wilma Burdis

Raymond James

―

Hold

―

Reiterated

06/30/25

Kevin Heal

Argus Research

$93

Buy

15.06%

Upside

Reiterated

02/25/25

Argus Research Keeps Their Buy Rating on Metlife (MET)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Andrew Kligerman

TD Cowen

$90→$91

Buy

12.58%

Upside

Reiterated

08/22/25

TD Cowen Sticks to Their Buy Rating for Metlife (MET)We reiterate Buy.

Bob Huang

Morgan Stanley

$98→$94

Buy

16.29%

Upside

Reiterated

08/18/25

Morgan Stanley Keeps Their Buy Rating on Metlife (MET)MET.N MetLife Inc. Overweight with price target change from 98.00 to 94.00.

Jimmy Bhullar

J.P. Morgan

$95→$94

Buy

16.29%

Upside

Reiterated

08/14/25

J.P. Morgan Sticks to Its Buy Rating for Metlife (MET)JPMorgan analyst Jimmy Bhullar lowered the price target on MetLife (NYSE: MET) to $94.00 (from $95.00) while maintaining a Overweight rating.

Jack Matten

BMO Capital

$90→$82

Hold

1.45%

Upside

Reiterated

08/13/25

Ryan Krueger

KBW

$94→$92

Buy

13.82%

Upside

Reiterated

08/12/25

KBW Keeps Their Buy Rating on Metlife (MET)

Suneet Kamath

Jefferies

$100→$103

Buy

27.43%

Upside

Reiterated

08/11/25

Jefferies Reaffirms Their Buy Rating on Metlife (MET)Jefferies analyst Suneet Kamath raised the price target on MetLife (NYSE: MET) to $103.00 (from $100.00) while maintaining a Buy rating.

Elyse Greenspan

Wells Fargo

$97→$95

Buy

17.53%

Upside

Reiterated

08/11/25

MetLife price target lowered to $95 from $97 at Wells FargoMetLife price target lowered to $95 from $97 at Wells Fargo

Thomas Gallagher

Evercore ISI

$110→$108

Buy

33.61%

Upside

Reiterated

08/08/25

Evercore ISI Sticks to Their Buy Rating for Metlife (MET)

John Barnidge

Piper Sandler

$94

Buy

16.29%

Upside

Reiterated

08/07/25

Analysts' Opinions Are Mixed on These Financial Stocks: CF Bankshares (NASDAQ: CFBK), Metlife (NYSE: MET) and TriplePoint Venture Growth (NYSE: TPVG)

Michael Ward CFA

UBS

$94→$91

Buy

12.58%

Upside

Reiterated

08/07/25

Metlife (MET) Receives a Buy from UBS

Alex Scott

Barclays

$94→$93

Buy

15.06%

Upside

Reiterated

08/07/25

Barclays Sticks to Its Buy Rating for Metlife (MET)

Joshua Shanker

Bank of America Securities

$100

Buy

23.72%

Upside

Reiterated

08/06/25

Analysts Conflicted on These Financial Names: Carlyle Group (NASDAQ: CG), Quilter (Other OTC: QUILF) and Metlife (NYSE: MET)

Wilma Burdis

Raymond James

―

Hold

―

Reiterated

06/30/25

Kevin Heal

Argus Research

$93

Buy

15.06%

Upside

Reiterated

02/25/25

Argus Research Keeps Their Buy Rating on Metlife (MET)

Stocks with the Highest Top Analyst Consensus in the Financial Sector

xxx

Find stocks in the Financial sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Metlife

1 Month

xxx

Success Rate

24/35 ratings generated profit

Average Return

+2.37%

reiterated a xxx

rating 16 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 68.57% of your transactions generating a profit, with an average return of +2.37% per trade.

3 Months

xxx

Success Rate

23/35 ratings generated profit

Average Return

+4.31%

reiterated a xxx

rating 16 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 65.71% of your transactions generating a profit, with an average return of +4.31% per trade.

1 Year

Ryan KruegerKBW

Success Rate

28/31 ratings generated profit

Average Return

+17.16%

reiterated a buy rating 15 days ago

Copying Ryan Krueger's trades and holding each position for 1 Year would result in 90.32% of your transactions generating a profit, with an average return of +17.16% per trade.

2 Years

xxx

Success Rate

26/28 ratings generated profit

Average Return

+16.83%

reiterated a xxx

rating 20 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 92.86% of your transactions generating a profit, with an average return of +16.83% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MET Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MET has received 38 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. MET average Analyst price target in the past 3 months is 94.75.

Each month's total comprises the sum of three months' worth of ratings.

MET Financial Forecast

MET Earnings Forecast

Next quarter’s earnings estimate for MET is $2.29 with a range of $2.09 to $2.42. The previous quarter’s EPS was $2.02. MET beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 56.25% of the time in the same period. In the last calendar year MET has Preformed in-line its overall industry.

MET Sales Forecast

Next quarter’s sales forecast for MET is $18.73B with a range of $18.20B to $19.40B. The previous quarter’s sales results were $17.34B. MET beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 78.00% of the time in the same period. In the last calendar year MET has Outperformed its overall industry.

MET Stock Forecast FAQ

What is MET’s average 12-month price target, according to analysts?

Based on analyst ratings, Metlife’s 12-month average price target is 94.75.

What is MET’s upside potential, based on the analysts’ average price target?

Metlife has 17.22% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MET a Buy, Sell or Hold?

Metlife has a consensus rating of Strong Buy which is based on 11 buy ratings, 2 hold ratings and 0 sell ratings.

What is Metlife’s price target?

The average price target for Metlife is 94.75. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $108.00 ,the lowest forecast is $82.00. The average price target represents 17.22% Increase from the current price of $80.83.

What do analysts say about Metlife?

Metlife’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of MET?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Metlife (MET) Stock Forecast & Price Target

MET Analyst Ratings

MET Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Metlife

MET Analyst Recommendation Trends

MET Financial Forecast

MET Earnings Forecast

MET Sales Forecast

MET Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts